Literature DB >> 18425623

Use of the TIMI frame count in the assessment of coronary artery blood flow and microvascular function over the past 15 years.

Vijayalakshmi Kunadian1, Caitlin Harrigan, Cafer Zorkun, Alexandra M Palmer, Katherine J Ogando, Leah H Biller, Erin E Lord, Scott P Williams, Michelle E Lew, Lauren N Ciaglo, Jacqueline L Buros, Susan J Marble, William J Gibson, C Michael Gibson.   

Abstract

Since its introduction, the TIMI frame count method has contributed to the understanding of the pathophysiology of coronary artery disease. In this article, the evolution of the TFC method and its applicability in the assessment of various therapeutic modalities are described.

Entities:  

Mesh:

Year:  2008        PMID: 18425623     DOI: 10.1007/s11239-008-0220-3

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  94 in total

1.  The value of the TIMI frame count method in the diagnosis of coronary no-reflow: a comparison with myocardial perfusion SPECT in patients with acute myocardial infarction.

Authors:  M Sahin; T Basoglu; F Canbaz; M Elcik; A Kosus
Journal:  Nucl Med Commun       Date:  2002-12       Impact factor: 1.690

2.  Effects of abciximab on microvascular integrity and left ventricular functional recovery in patients with acute infarction treated by primary coronary angioplasty.

Authors:  A S Petronio; D Rovai; G Musumeci; R Baglini; C Nardi; U Limbruno; C Palagi; D Volterrani; M Mariani
Journal:  Eur Heart J       Date:  2003-01       Impact factor: 29.983

3.  Novel index for invasively assessing the coronary microcirculation.

Authors:  William F Fearon; Leora B Balsam; H M Omar Farouque; Anthony D Caffarelli; Robert C Robbins; Peter J Fitzgerald; Paul G Yock; Alan C Yeung
Journal:  Circulation       Date:  2003-06-23       Impact factor: 29.690

4.  Myocardial resistance assessed by guidewire-based pressure-temperature measurement: in vitro validation.

Authors:  Wilbert Aarnoudse; Petra van den Berg; Frans van de Vosse; Maartje Geven; Marcel Rutten; Mark Van Turnhout; William Fearon; Bernard de Bruyne; Nico Pijls
Journal:  Catheter Cardiovasc Interv       Date:  2004-05       Impact factor: 2.692

5.  A randomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarction.

Authors:  Christophe Loubeyre; Marie-Claude Morice; Thierry Lefèvre; Jean-François Piéchaud; Yves Louvard; Pierre Dumas
Journal:  J Am Coll Cardiol       Date:  2002-01-02       Impact factor: 24.094

6.  Quantitative angiographic and statistical methods to assess serial changes in coronary luminal diameter and implications for atherosclerosis regression trials.

Authors:  C M Gibson; T Sandor; P H Stone; R C Pasternak; B Rosner; F M Sacks
Journal:  Am J Cardiol       Date:  1992-05-15       Impact factor: 2.778

7.  Thrombolysis in Myocardial Infarction frame count in saphenous vein grafts.

Authors:  E N Al-Mousa; J T Dodge; M Rizzo; C McLean; K Ryan; J Moynihan; M Kelley; S J Marble; M Goel; W L Daley; C M Gibson
Journal:  Am Heart J       Date:  1998-02       Impact factor: 4.749

8.  Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial.

Authors:  Gregg W Stone; John Webb; David A Cox; Bruce R Brodie; Mansoor Qureshi; Anna Kalynych; Mark Turco; Heinz P Schultheiss; Daniel Dulas; Barry D Rutherford; David Antoniucci; Mitchell W Krucoff; Raymond J Gibbons; Denise Jones; Alexandra J Lansky; Roxana Mehran
Journal:  JAMA       Date:  2005-03-02       Impact factor: 56.272

9.  Correlates of coronary blood flow before and after percutaneous coronary intervention and their relationship to angiographic and clinical outcomes in the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis.

Authors:  C Michael Gibson; M Imran Dotani; Sabina A Murphy; Susan J Marble; Kent W Dauterman; Andrew D Michaels; J Theodore Dodge
Journal:  Am Heart J       Date:  2002-07       Impact factor: 4.749

10.  The angiographic and clinical benefits of mibefradil in the coronary slow flow phenomenon.

Authors:  John F Beltrame; Stuart P Turner; Sue L Leslie; Patty Solomon; Saul B Freedman; John D Horowitz
Journal:  J Am Coll Cardiol       Date:  2004-07-07       Impact factor: 24.094

View more
  11 in total

1.  Predictive value of the corrected TIMI frame count in patients with suspected angina pectoris but no obstructive coronary artery disease at angiography.

Authors:  Lasse Jespersen; Steen Z Abildstrøm; Adam Peña; Peter R Hansen; Eva Prescott
Journal:  Clin Res Cardiol       Date:  2014-01-20       Impact factor: 5.460

2.  An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group.

Authors:  Vijay Kunadian; Alaide Chieffo; Paolo G Camici; Colin Berry; Javier Escaned; Angela H E M Maas; Eva Prescott; Nicole Karam; Yolande Appelman; Chiara Fraccaro; Gill Louise Buchanan; Stephane Manzo-Silberman; Rasha Al-Lamee; Evelyn Regar; Alexandra Lansky; J Dawn Abbott; Lina Badimon; Dirk J Duncker; Roxana Mehran; Davide Capodanno; Andreas Baumbach
Journal:  Eur Heart J       Date:  2020-10-01       Impact factor: 29.983

3.  Predictors of recurrent angina in patients with no need for secondary revascularization.

Authors:  Tian Xu; Ya Li; Li-Ding Zhao; Guo-Sheng Fu; Wen-Bin Zhang
Journal:  World J Emerg Med       Date:  2021

4.  Myocardial perfusion reserve and global longitudinal strain as potential markers of coronary allograft vasculopathy in late-stage orthotopic heart transplantation.

Authors:  Akhil Narang; John E Blair; Mita B Patel; Victor Mor-Avi; Savitri E Fedson; Nir Uriel; Roberto M Lang; Amit R Patel
Journal:  Int J Cardiovasc Imaging       Date:  2018-05-04       Impact factor: 2.357

Review 5.  The Human Microcirculation: Regulation of Flow and Beyond.

Authors:  David D Gutterman; Dawid S Chabowski; Andrew O Kadlec; Matthew J Durand; Julie K Freed; Karima Ait-Aissa; Andreas M Beyer
Journal:  Circ Res       Date:  2016-01-08       Impact factor: 17.367

6.  ST segment resolution in patients with tenecteplase-facilitated percutaneous coronary intervention versus tenecteplase alone: Insights from the Combined Angioplasty and Pharmacological Intervention versus Thrombolysis ALone in Acute Myocardial Infarction (CAPITAL AMI) trial.

Authors:  D Y So; A C Ha; R F Davies; M Froeschl; G A Wells; M R Le May
Journal:  Can J Cardiol       Date:  2010-01       Impact factor: 5.223

7.  The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised controlled trial.

Authors:  Sheraz A Nazir; Jamal N Khan; Islam Z Mahmoud; John P Greenwood; Daniel J Blackman; Vijay Kunadian; Martin Been; Keith R Abrams; Robert Wilcox; A A Jennifer Adgey; Gerry P McCann; Anthony H Gershlick
Journal:  Trials       Date:  2014-09-25       Impact factor: 2.279

8.  Epicardial adipose tissue thickness is associated with myocardial infarction and impaired coronary perfusion.

Authors:  Aslı Tanındı; Sinan Altan Kocaman; Aycan Fahri Erkan; Murat Uğurlu; Aslıhan Alhan; Hasan Fehmi Töre
Journal:  Anatol J Cardiol       Date:  2014-02-26       Impact factor: 1.596

Review 9.  Sweat the small stuff: The human microvasculature and heart disease.

Authors:  Boran Katunaric; Katie E Cohen; Andreas M Beyer; David D Gutterman; Julie K Freed
Journal:  Microcirculation       Date:  2020-09-29       Impact factor: 2.679

10.  Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction.

Authors:  Lara S F Konijnenberg; Peter Damman; Dirk J Duncker; Robert A Kloner; Robin Nijveldt; Robert-Jan M van Geuns; Colin Berry; Niels P Riksen; Javier Escaned; Niels van Royen
Journal:  Cardiovasc Res       Date:  2020-03-01       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.